05:04 PM EDT, 10/16/2025 (MT Newswires) -- Lexeo Therapeutics ( LXEO ) said late Thursday it has launched a public offering alongside a private placement of shares.

The company will give underwriters a 30-day option to buy additional shares.

The clinical stage genetic medicine company also plans to sell shares and pre-funded warrants in place of common stock to Balyasny Asset Management in a private placement.

Shares were down around 3.2% in recent after-market trade.